Seventeen percent of hospitals offered computed tomographic colonography in 2008 compared to 13 percent in 2005, according to a study published in Journal of the American College of Radiology.
GI & Endoscopy
Clinical Trial Tests Gastric Bypass Surgery for Type 2 Diabetes in Overweight, Mildly Obese Patients
NewYork-Presbyterian Hospital/Weill Cornell Medical Center is conducting the first clinical trial to test surgery for Type 2 Diabetes in overweight or mildly obese patients, according to a news release.
Endoscopic removal of precancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended over surveillance, according to a medical position statement by the American Gastroenterological Institute.
Joe Zuerker, MD, Leann Serbousek, MD, Randy Kakish, MD, Karen Kindley, MD, and Vijay Prabhu, MD, all board-certified gastroenterologists, have joined the medical staff of Mercy Clinic in Oklahoma City, according to a NewsOK news report.
Researchers have developed a three-dimensional tissue model of the human intestine to study gastrointestinal diseases, according to a Cornell University Chronicle Online report.
Baylor Research Institute, the research arm of Baylor Health Care System, and Eureka Genomics have partnered to study the causes of colorectal cancer for the advancement of the disease's prevention, management and treatment, according to a news release.
Bovine colostrum may reduce intestinal permeability of luminal toxins caused by heavy exercise in athletes, according to an article published in the American Journal of Physiology- Gastrointestinal and Liver Physiology.
Cook Medical has developed a new histology needle for endoscopic ultrasound that provides a minimally invasive procedure for taking samples of submucosal lesions, mediastinal masses, lymph nodes and intraperitoneal masses, according to a news release by the company.
New technology now allows GI physicians to remove patients' gallstones without open abdominal surgery and a hospital stay, avoiding longer recovery times and higher healthcare costs, according to an Albany Herald news report.
Avastin, in combination with chemotherapy, was expected to extend the lifespan of patients with cancer, including advanced colorectal tumors, by many years but is failing to live up to that expectation, according to a Bloomberg Businessweek news report.
